Search the Appendices of Resolution CM/Res(2018)1
2559 found
INN | ATC Code ▲ | Country | Classification | Last update | MA Number | Registration date | Status | |
---|---|---|---|---|---|---|---|---|
TRASTUZUMAB | L01FD01 | RO | I | 1260 | 24-11-2000 | VALID | ||
PERTUZUMAB | L01FD02 | RO | POM | VALID | ||||
TRASTUZUMAB EMTANSINE | L01FD03 | RO | I | None | VALID | |||
TRASTUZUMAB DERUXTECAN | L01FD04 | RO | I | 06-12-2021 | EMEA/H/C/005124 | 18-01-2021 | VALID | |
PANITUMUMAB | L01FE02 | RO | I | None | VALID | |||
NECITUMUMAB | L01FE03 | RO | Not authorised | 21-11-2016 | VALID | |||
NIVOLUMAB | L01FF01 | RO | I | 22-09-2017 | EMEA/H/C/003985 | 19-06-2015 | VALID | |
PEMBROLIZUMAB | L01FF02 | RO | I | 22-09-2017 | EMEA/H/C/003820 | 17-07-2015 | VALID | |
DURVALUMAB | L01FF03 | RO | I | 12-11-2018 | EMEA/H/C/004771 | 20-09-2018 | VALID | |
AVELUMAB | L01FF04 | RO | I | VALID | ||||
CEMIPLIMAB | L01FF06 | RO | I | 05-10-2020 | EMEA/H/C/004844 | 27-06-2019 | VALID | |
DOSTARLIMAB | L01FF07 | RO | I | 06-12-2021 | EMEA/H/C/005204 | 21-04-2021 | VALID | |
TISLELIZUMAB | L01FF09 | RO | Not authorised | 20-11-2023 | VALID | |||
RAMUCIRUMAB | L01FG02 | RO | I | VALID | ||||
GEMTUZUMAB OZOGAMICIN | L01FX02 | RO | I | 06-12-2021 | VALID | |||
IPILIMUMAB | L01FX04 | RO | I | None | VALID | |||
BRENTUXIMAB VEDOTIN | L01FX05 | RO | I | VALID | ||||
DINUTUXIMAB BETA | L01FX06 | RO | I | 05-10-2020 | EMEA/H/C/003918 | 08-05-2017 | VALID | |
BLINATUMOMAB | L01FX07 | RO | I | 19-02-2019 | VALID | |||
ELOTUZUMAB | L01FX08 | RO | Not authorised | 21-11-2016 | VALID | |||
MOGAMULIZUMAB | L01FX09 | RO | I | 05-10-2020 | EMEA/H/C/004232 | 22-11-2018 | VALID | |
OLARATUMAB | L01FX10 | RO | Not authorised | 29-05-2017 | VALID | |||
TAFASITAMAB | L01FX12 | RO | I | 06-12-2021 | EMEA/H/C/005436 | 26-08-2021 | VALID | |
ENFORTUMAB VEDOTIN | L01FX13 | RO | Not authorised | 21-11-2022 | VALID | |||
POLATUZUMAB VEDOTIN | L01FX14 | RO | I | VALID | ||||
SACITUZUMAB GOVITECAN | L01FX17 | RO | I | 18-11-2022 | EMEA/H/C/005182 | 22-11-2021 | VALID | |
AMIVANTAMAB | L01FX18 | RO | I | 18-11-2022 | EMEA/H/C/005454 | 09-12-2021 | VALID | |
TREMELIMUMAB | L01FX20 | RO | I | 03-10-2023 | EMEA/H/C/004650 | 20-02-2023 | VALID | |
LONCASTUXIMAB TESIRINE | L01FX22 | RO | I | 03-10-2023 | EMEA/H/C/005685 | 20-12-2022 | VALID | |
GLOFITAMAB | L01FX28 | RO | I | 15-11-2023 | EMEA/H/C/005751 | 07-07-2023 | VALID | |
TALQUETAMAB | L01FX29 | RO | I | 15-11-2023 | EMEA/H/C/005864 | 21-08-2023 | VALID | |
ELRANATAMAB | L01FX32 | RO | Not authorised | 14-05-2024 | VALID | |||
PERTUZUMAB AND TRASTUZUMAB | L01FY01 | RO | I | 06-09-2023 | VALID | |||
NIVOLUMAB AND RELATLIMAB | L01FY02 | RO | POM | 22-11-2023 | EMEA/H/C/005481 | 15-09-2022 | VALID | |
CISPLATIN | L01XA01 | RO | I | 3607 | 11-07-2003 | VALID | ||
CARBOPLATIN | L01XA02 | RO | I | 1937 | 21-05-2001 | VALID | ||
OXALIPLATIN | L01XA03 | RO | I | 147 | 23-06-1999 | VALID | ||
PROCARBAZINE | L01XB01 | RO | I | 7699 | 12-01-1999 | VALID | ||
TRASTUZUMAB | L01XC03 | RO | I | 14-05-2024 | EMEA/H/C/005769 | 15-11-2023 | VALID | |
CETUXIMAB | L01XC06 | RO | I | None | VALID | |||
PORFIMER SODIUM | L01XD01 | RO | I | None | VALID | |||
AMINOLEVULINIC ACID | L01XD04 | RO | I | 23-02-2017 | VALID | |||
TEMOPORFIN | L01XD05 | RO | I | 3455 | 28-05-2003 | VALID | ||
PADELIPORFIN | L01XD07 | RO | Not authorised | 04-05-2018 | VALID | |||
FEDRATINIB | L01XE57 | RO | I | 06-12-2021 | EMEA/H/C/005026 | 08-02-2021 | VALID | |
TRETINOIN | L01XF01 | RO | I | 1919 | 16-05-2001 | VALID | ||
ALITRETINOIN | L01XF02 | RO | Not authorised | 23-01-2019 | VALID | |||
BEXAROTENE | L01XF03 | RO | Not authorised | 23-01-2019 | VALID | |||
BORTEZOMIB | L01XG01 | RO | I | 09-03-2020 | VALID | |||
IXAZOMIB | L01XG03 | RO | POM | 24-04-2017 | EMEA/H/C/003844 | 21-11-2016 | VALID |